US stock screener
Every US-listed company we cover, ranked by what it reported to the SEC. Figures come from each company’s own filings (P/E and dividend yield combine SEC share counts and TTM results with a daily price snapshot). Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
558 companies in Healthcare · page 2 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | Healthcare | $7.33B | $2.35B | 59.0% | 5.5% | 23.7% | — | — |
| EXELIXIS, INC. (EXEL) | Healthcare | $14.11B | $2.32B | 7.0% | 33.7% | 36.2% | 18.6 | — |
| Natera, Inc. (NTRA) | Healthcare | $37.91B | $2.31B | 35.9% | -9.0% | -12.2% | — | — |
| Enovis CORP (ENOV) | Healthcare | $1.56B | $2.25B | 6.7% | -52.7% | -79.4% | — | — |
| ICU MEDICAL INC/DE (ICUI) | Healthcare | $3.93B | $2.23B | -6.3% | 0.0% | 0.0% | 84.6 | — |
| Sarepta Therapeutics, Inc. (SRPT) | Healthcare | $1.82B | $2.20B | 15.6% | -32.5% | -62.5% | 11.4 | — |
| Concentra Group Holdings Parent, Inc. (CON) | Healthcare | $4.03B | $2.16B | 13.9% | 7.7% | 41.5% | 22.7 | 1.0% |
| Privia Health Group, Inc. (PRVA) | Healthcare | $3.39B | $2.12B | 22.3% | 1.1% | 2.9% | 168 | — |
| QIAGEN N.V. (QGEN) | Healthcare | $8.49B | $2.09B | 5.7% | 20.3% | 11.2% | — | — |
| RadNet, Inc. (RDNT) | Healthcare | $4.89B | $2.04B | 11.5% | -0.9% | -1.4% | — | — |
| TELEFLEX INC (TFX) | Healthcare | — | $1.99B | 17.2% | -45.4% | -29.0% | — | 1.0% |
| National Vision Holdings, Inc. (EYE) | Healthcare | $1.60B | $1.99B | 9.0% | 1.5% | 3.4% | 35.1 | — |
| Moderna, Inc. (MRNA) | Healthcare | $22.62B | $1.94B | -39.9% | — | -32.6% | — | — |
| Pediatrix Medical Group, Inc. (MD) | Healthcare | — | $1.91B | -4.9% | 8.6% | 19.1% | 12.7 | — |
| MSA Safety Inc (MSA) | Healthcare | $6.60B | $1.87B | 3.7% | 14.9% | 20.4% | 23.1 | 1.3% |
| Integer Holdings Corp (ITGR) | Healthcare | $3.24B | $1.85B | 8.0% | 5.5% | 5.9% | 23.9 | — |
| HEALTHCARE SERVICES GROUP INC (HCSG) | Healthcare | $1.74B | $1.84B | 7.1% | 3.2% | 11.6% | 26.6 | — |
| PTC THERAPEUTICS, INC. (PTCT) | Healthcare | $6.52B | $1.73B | 114.5% | 39.4% | — | — | — |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | Healthcare | $1.50B | $1.64B | 1.5% | -31.6% | -49.5% | — | — |
| Lantheus Holdings, Inc. (LNTH) | Healthcare | $7.00B | $1.54B | 0.5% | 15.2% | 21.4% | 26.0 | — |
| MASIMO CORP (MASI) | Healthcare | — | $1.53B | 9.4% | -9.9% | -21.0% | — | — |
| MERIT MEDICAL SYSTEMS INC (MMSI) | Healthcare | $4.41B | $1.52B | 11.8% | 8.5% | 8.1% | 31.9 | — |
| Alkermes plc. (ALKS) | Healthcare | $8.83B | $1.48B | -5.2% | 16.4% | 13.3% | 58.9 | — |
| NATIONAL HEALTHCARE CORP (NHC) | Healthcare | $3.56B | $1.47B | 17.4% | 8.2% | 11.2% | 29.0 | 1.1% |
| P3 Health Partners Inc. (PIII) | Healthcare | $2.20B | $1.46B | -2.8% | -10.1% | — | — | — |
| LifeStance Health Group, Inc. (LFST) | Healthcare | $4.42B | $1.42B | 13.9% | 0.7% | 0.6% | — | — |
| Addus HomeCare Corp (ADUS) | Healthcare | $2.09B | $1.42B | 23.2% | 6.7% | 8.8% | 20.6 | — |
| Penumbra Inc (PEN) | Healthcare | $12.52B | $1.40B | 17.5% | 12.7% | 12.4% | 73.3 | — |
| HALOZYME THERAPEUTICS, INC. (HALO) | Healthcare | $9.23B | $1.40B | 37.6% | 22.7% | 649.2% | 27.2 | — |
| LivaNova PLC (LIVN) | Healthcare | $4.43B | $1.39B | 10.7% | -17.5% | -20.2% | 41.4 | — |
| CONMED Corp (CNMD) | Healthcare | $1.24B | $1.37B | 5.2% | 3.4% | 4.6% | 27.3 | 1.9% |
| HAEMONETICS CORP (HAE) | Healthcare | $3.54B | $1.33B | -2.0% | 7.3% | 12.2% | 38.0 | — |
| PHIBRO ANIMAL HEALTH CORP (PAHC) | Healthcare | $1.35B | $1.30B | 27.4% | 3.7% | 16.9% | 14.2 | — |
| Progyny, Inc. (PGNY) | Healthcare | $2.50B | $1.29B | 10.4% | 4.5% | 11.3% | 41.5 | — |
| Curaleaf Holdings, Inc. (CURLF) | Healthcare | $2.44B | $1.27B | -5.0% | -18.2% | — | — | — |
| Indivior Pharmaceuticals, Inc. (INDV) | Healthcare | $4.79B | $1.24B | 4.3% | 16.9% | — | 20.8 | — |
| Nasus Pharma Ltd (NSRX) | Healthcare | $35.2M | $1.24B | — | -0.5% | -211.6% | — | — |
| BIO-TECHNE Corp (TECH) | Healthcare | $11.24B | $1.22B | 5.2% | 6.0% | 3.8% | 105 | 0.4% |
| Trulieve Cannabis Corp. (TRLV) | Healthcare | $1.69B | $1.18B | -0.4% | -9.9% | -10.2% | — | — |
| Sotera Health Co (SHC) | Healthcare | $5.06B | $1.16B | 5.7% | 6.7% | 12.9% | 43.3 | — |
| NOVAVAX INC (NVAX) | Healthcare | $1.35B | $1.12B | 64.7% | 39.2% | — | — | — |
| Prestige Consumer Healthcare Inc. (PBH) | Healthcare | — | $1.09B | -4.3% | 17.5% | 10.1% | 12.8 | — |
| Embecta Corp. (EMBC) | Healthcare | $192.8M | $1.08B | -3.8% | 8.8% | — | 1.7 | 18.3% |
| ACADIA PHARMACEUTICALS INC (ACAD) | Healthcare | $4.38B | $1.07B | 11.9% | 36.5% | 31.9% | 11.6 | — |
| TANDEM DIABETES CARE INC (TNDM) | Healthcare | $1.17B | $1.01B | 7.9% | -20.2% | -131.9% | — | — |
| ONTO INNOVATION INC. (ONTO) | Healthcare | $13.92B | $1.01B | 1.8% | 13.6% | 6.5% | 131 | — |
| Guardant Health, Inc. (GH) | Healthcare | $19.92B | $982.0M | 32.9% | -42.4% | — | — | — |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Healthcare | $12.76B | $958.4M | 432.1% | -30.1% | -47.8% | — | — |
| Pennant Group, Inc. (PNTG) | Healthcare | $1.46B | $947.7M | 36.3% | 3.1% | 7.9% | 48.8 | — |
| IONIS PHARMACEUTICALS INC (IONS) | Healthcare | $8.99B | $943.7M | 33.8% | -40.4% | -78.0% | — | — |
| Mirion Technologies, Inc. (MIR) | Healthcare | $3.91B | $925.4M | 7.5% | 3.1% | 1.5% | 160 | — |
| USANA HEALTH SCIENCES INC (USNA) | Healthcare | $402.9M | $925.3M | 8.3% | 1.2% | — | 45.5 | — |
| Inspire Medical Systems, Inc. (INSP) | Healthcare | $1.46B | $912.0M | 13.6% | 15.9% | 18.6% | 11.5 | — |
| NEOGEN CORP (NEOG) | Healthcare | $2.24B | $894.7M | -3.2% | — | -52.7% | — | — |
| ANI PHARMACEUTICALS INC (ANIP) | Healthcare | $1.80B | $883.4M | 43.8% | 8.9% | 14.5% | 20.1 | — |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | Healthcare | $2.36B | $874.8M | 94.1% | 30.2% | — | — | — |
| Warby Parker Inc. (WRBY) | Healthcare | $3.24B | $871.9M | 13.0% | 0.2% | 0.4% | 1320 | — |
| Harmony Biosciences Holdings, Inc. (HRMY) | Healthcare | $1.96B | $868.5M | 21.5% | 18.3% | 18.2% | 13.6 | — |
| InnovAge Holding Corp. (INNV) | Healthcare | $1.56B | $853.7M | 11.8% | -3.6% | — | — | — |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Healthcare | $10.47B | $829.4M | 23258.2% | -0.2% | -0.3% | — | — |
| MYRIAD GENETICS INC (MYGN) | Healthcare | $583.7M | $824.5M | -1.6% | -44.4% | -99.4% | — | — |
| Orthofix Medical Inc. (OFIX) | Healthcare | $468.1M | $822.3M | 2.9% | -11.2% | -20.5% | — | — |
| Tilray Brands, Inc. (TLRY) | Healthcare | $530.9M | $821.3M | 4.1% | — | -146.8% | — | — |
| Caris Life Sciences, Inc. (CAI) | Healthcare | $4.66B | $812.0M | 97.0% | -8.4% | -11.8% | — | — |
| U S PHYSICAL THERAPY INC /NV (USPH) | Healthcare | $1.12B | $781.0M | 16.3% | 5.1% | — | — | — |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | Healthcare | $1.17B | $780.6M | 23.6% | 8.1% | 20.8% | 17.8 | — |
| Alphatec Holdings, Inc. (ATEC) | Healthcare | $1.31B | $764.2M | 25.0% | -18.8% | -1153.7% | — | — |
| CORCEPT THERAPEUTICS INC (CORT) | Healthcare | $9.72B | $761.4M | 12.8% | 13.1% | 15.4% | 259 | — |
| iRhythm Holdings, Inc. (IRTC) | Healthcare | $3.64B | $747.1M | 26.2% | -6.0% | -29.2% | — | — |
| Emergent BioSolutions Inc. (EBS) | Healthcare | $393.7M | $742.9M | -28.8% | 7.1% | 10.1% | — | — |
| REPLIGEN CORP (RGEN) | Healthcare | $8.31B | $738.3M | 16.4% | 6.6% | 2.3% | 164 | — |
| Pacira BioSciences, Inc. (PCRX) | Healthcare | $1.01B | $726.4M | 3.6% | 1.0% | 1.0% | 213 | — |
| Amphastar Pharmaceuticals, Inc. (AMPH) | Healthcare | $870.6M | $719.9M | -1.7% | 13.6% | 12.4% | 11.9 | — |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Healthcare | $2.79B | $719.0M | 8.6% | -5.4% | -3.6% | — | — |
| AVANOS MEDICAL, INC. (AVNS) | Healthcare | $1.17B | $701.2M | 1.9% | -10.4% | -9.4% | — | — |
| Kiniksa Pharmaceuticals International, plc (KNSA) | Healthcare | $4.92B | $677.6M | 60.1% | 8.7% | 10.4% | 70.3 | — |
| Ultragenyx Pharmaceutical Inc. (RARE) | Healthcare | $2.88B | $673.0M | 20.2% | -85.4% | — | — | — |
| Cresco Labs Inc. (CRLBF) | Healthcare | $277.9M | $655.8M | -9.5% | -20.6% | -53.6% | — | — |
| NovoCure Ltd (NVCR) | Healthcare | $1.84B | $655.4M | 8.3% | -20.8% | -40.0% | — | — |
| 10x Genomics, Inc. (TXG) | Healthcare | $5.55B | $642.8M | 5.2% | -6.8% | -5.5% | — | — |
| Axsome Therapeutics, Inc. (AXSM) | Healthcare | $11.84B | $638.5M | 65.5% | -28.7% | -207.5% | — | — |
| TG THERAPEUTICS, INC. (TGTX) | Healthcare | $8.40B | $616.3M | 87.3% | 72.6% | 69.0% | 19.1 | — |
| Cadre Holdings, Inc. (CDRE) | Healthcare | $1.24B | $610.3M | 7.5% | 7.2% | 13.9% | 34.2 | 1.3% |
| OPKO HEALTH, INC. (OPK) | Healthcare | $898.6M | $606.9M | -14.9% | -37.2% | -17.8% | — | — |
| INSMED Inc (INSM) | Healthcare | $23.28B | $606.4M | 66.7% | — | -172.8% | — | — |
| TransMedics Group, Inc. (TMDX) | Healthcare | $2.56B | $605.5M | 37.1% | 31.4% | 40.2% | 16.9 | — |
| UFP TECHNOLOGIES INC (UFPT) | Healthcare | $1.87B | $602.8M | 19.5% | 11.3% | 16.1% | 27.5 | — |
| CATALYST PHARMACEUTICALS, INC. (CPRX) | Healthcare | $3.85B | $589.0M | 19.8% | 36.4% | 22.5% | 18.1 | — |
| Bioventus Inc. (BVS) | Healthcare | $817.0M | $568.1M | -0.9% | 4.0% | 10.0% | 29.4 | — |
| Organogenesis Holdings Inc. (ORGO) | Healthcare | $338.4M | $564.2M | 17.0% | 6.6% | — | — | — |
| HUTCHMED (China) Ltd (HCM) | Healthcare | $1.86B | $548.5M | -13.0% | 83.3% | 36.5% | — | — |
| AtriCure, Inc. (ATRC) | Healthcare | $1.77B | $534.5M | 14.9% | -2.1% | -2.3% | — | — |
| Mirum Pharmaceuticals, Inc. (MIRM) | Healthcare | $7.11B | $521.3M | 54.7% | -4.5% | -7.4% | — | — |
| VERACYTE, INC. (VCYT) | Healthcare | $4.57B | $517.1M | 16.0% | 12.8% | 5.1% | 53.0 | — |
| Inotiv, Inc. (NOTVQ) | Healthcare | $390,419 | $513.0M | 4.5% | -13.4% | -50.4% | — | — |
| ADMA BIOLOGICS, INC. (ADMA) | Healthcare | $2.02B | $510.2M | 19.6% | 28.8% | 30.8% | 12.8 | — |
| GLAUKOS Corp (GKOS) | Healthcare | $9.13B | $507.4M | 32.3% | -37.0% | -28.6% | — | — |
| Oncology Institute, Inc. (TOI) | Healthcare | $549.9M | $502.7M | 27.8% | -12.1% | — | — | — |
| BridgeBio Pharma, Inc. (BBIO) | Healthcare | $15.94B | $502.1M | 126.3% | — | — | — | — |
| Ascend Wellness Holdings, Inc. (AAWH) | Healthcare | $91.4M | $500.6M | -10.9% | -23.6% | — | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR (public domain), as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.